BATS BZX Real-Time Price
As of 1:59pm ET
| +0.61 / +2.65%|
The 9 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 15.00, with a high estimate of 30.00 and a low estimate of 12.00. The median estimate represents a -36.55% decrease from the last price of 23.64.
The current consensus among 9 polled investment analysts is to Hold stock in Clovis Oncology Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.